Clinical Characteristics Associated with the PLP-PLS Index, a New Potential Metric to Phenotype Phantom Limb Pain.

adaptive neuroplasticity lower limb amputation phantom limb pain phantom limb sensation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 02 07 2024
revised: 04 08 2024
accepted: 05 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Phantom limb pain (PLP) is highly prevalent after amputation. However, the influence of non-painful sensations (PLS) remains unclear. This study examines the PLP-PLS index as a novel tool to differentiate PLP from PLS and explores the association of clinical factors with the index. We conducted a cross-sectional analysis of baseline data from 112 participants in a previous factorial trial in patients with unilateral traumatic lower limb amputation. Linear regression models were used to examine the associations between the index and various demographic, psychological and clinical factors. Logistic and Poisson regression, and e-value calculation were utilized for sensitivity analyses. Adjusted multivariable linear regression models demonstrated significant associations of phantom movement sensation (β: -1.532; 95% CI: -2.615 to -0.449; Time since amputation and phantom movement sensation likely reflect distinct phenotypes and potential mechanisms for PLP and PLS. The PLP-PLS index is a promising clinical tool for selecting therapies to prevent/treat PLP and for measuring treatment effects to modulate phantom pain. These findings emphasize the importance of understanding the mechanisms underlying PLP and PLS for improving clinical management and guiding future research.

Sections du résumé

BACKGROUND BACKGROUND
Phantom limb pain (PLP) is highly prevalent after amputation. However, the influence of non-painful sensations (PLS) remains unclear. This study examines the PLP-PLS index as a novel tool to differentiate PLP from PLS and explores the association of clinical factors with the index.
METHODS METHODS
We conducted a cross-sectional analysis of baseline data from 112 participants in a previous factorial trial in patients with unilateral traumatic lower limb amputation. Linear regression models were used to examine the associations between the index and various demographic, psychological and clinical factors. Logistic and Poisson regression, and e-value calculation were utilized for sensitivity analyses.
RESULTS RESULTS
Adjusted multivariable linear regression models demonstrated significant associations of phantom movement sensation (β: -1.532; 95% CI: -2.615 to -0.449;
CONCLUSIONS CONCLUSIONS
Time since amputation and phantom movement sensation likely reflect distinct phenotypes and potential mechanisms for PLP and PLS. The PLP-PLS index is a promising clinical tool for selecting therapies to prevent/treat PLP and for measuring treatment effects to modulate phantom pain. These findings emphasize the importance of understanding the mechanisms underlying PLP and PLS for improving clinical management and guiding future research.

Identifiants

pubmed: 39335548
pii: biomedicines12092035
doi: 10.3390/biomedicines12092035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Jorge Ortega-Márquez (J)

Master of Medical Sciences in Clinical Investigation, Harvard Medical School, Boston, MA 02115, USA.

Justyna Garnier (J)

Department of Psychology, SWPS University of Social Sciences and Humanities, 03-815 Warsaw, Poland.

Lucas Mena (L)

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo 05508-220, Brazil.

Ana Victoria Palagi Vigano (AV)

Grupo de Ombro e Cotovelo, Faculdade de Medicina do ABC, Santo André 09060-870, Brazil.

Eleonora Boschetti Grützmacher (EB)

Praxis Am Lichterfelde West, 12205 Berlin, Germany.

Gabriel Vallejos-Penaloza (G)

Departamento de Ginecología y Obstetricia, Facultad de Medicina, Clínica Alemana, Universidad del Desarrollo, Santiago 7610315, Chile.
Departamento de Ginecología y Obstetricia, Hospital Dr Luis Valentín Ferrada, Universidad Finis Terrae, Santiago 7501014, Chile.

Valton Costa (V)

Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
Laboratory of Neurosciences and Neurological Rehabilitation, Physical Therapy Department, Federal University of Sao Carlos, Sao Carlos 13565-905, Brazil.

Daniela Martinez-Magallanes (D)

Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.

Antonio Vaz de Macedo (A)

Hematology Clinic, Hospital da Polícia Militar, Belo Horizonte, Minas Gerais 30110-013, Brazil.

Waynice Neiva de Paula-Garcia (WN)

AC Camargo Cancer Center, São Paulo 01509-010, Brazil.

Denise Saretta Schwartz (DS)

Departamento de Clínica Médica, Faculdade de Medicina Veterinária e Zootecnia (FMVZ), Universidade de São Paulo, São Paulo 05508-220, Brazil.

Felipe Fregni (F)

Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.

Kevin Pacheco-Barrios (K)

Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
Unidad de Investigación para la Generación y Síntesis de Evidencia en Salud, Universidad San Ignacio de Loyola, Vicerrectorado de Investigación, Lima 15026, Peru.

Classifications MeSH